CN103664778B - A kind of synthetic method of antineoplastic drug cabozant inib - Google Patents
A kind of synthetic method of antineoplastic drug cabozant inib Download PDFInfo
- Publication number
- CN103664778B CN103664778B CN201310631287.3A CN201310631287A CN103664778B CN 103664778 B CN103664778 B CN 103664778B CN 201310631287 A CN201310631287 A CN 201310631287A CN 103664778 B CN103664778 B CN 103664778B
- Authority
- CN
- China
- Prior art keywords
- dimethoxy
- quinoline
- added
- water
- fluorophenyls
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000002176 L01XE26 - Cabozantinib Substances 0.000 title claims abstract description 11
- ONIQOQHATWINJY-UHFFFAOYSA-N cabozantinib Chemical compound C=12C=C(OC)C(OC)=CC2=NC=CC=1OC(C=C1)=CC=C1NC(=O)C1(C(=O)NC=2C=CC(F)=CC=2)CC1 ONIQOQHATWINJY-UHFFFAOYSA-N 0.000 title claims abstract description 11
- 229960001292 cabozantinib Drugs 0.000 title claims abstract description 11
- 238000010189 synthetic method Methods 0.000 title claims abstract description 9
- 239000002246 antineoplastic agent Substances 0.000 title claims abstract description 6
- 229940041181 antineoplastic drug Drugs 0.000 title claims abstract description 6
- 238000006243 chemical reaction Methods 0.000 claims abstract description 26
- PCDPMVJGEGAJBI-UHFFFAOYSA-N 6,7-dimethoxyquinoline Chemical compound C1=CN=C2C=C(OC)C(OC)=CC2=C1 PCDPMVJGEGAJBI-UHFFFAOYSA-N 0.000 claims abstract description 12
- 150000002118 epoxides Chemical class 0.000 claims abstract description 8
- 239000002994 raw material Substances 0.000 claims abstract description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 30
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 25
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 claims description 20
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 claims description 20
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 claims description 18
- 239000000243 solution Substances 0.000 claims description 17
- 230000015572 biosynthetic process Effects 0.000 claims description 16
- 238000003786 synthesis reaction Methods 0.000 claims description 16
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 14
- 239000012065 filter cake Substances 0.000 claims description 14
- 238000005160 1H NMR spectroscopy Methods 0.000 claims description 13
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 12
- 239000000843 powder Substances 0.000 claims description 12
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 12
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Substances ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 claims description 12
- 238000005406 washing Methods 0.000 claims description 12
- 239000000376 reactant Substances 0.000 claims description 11
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 claims description 10
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 claims description 10
- 238000003756 stirring Methods 0.000 claims description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 9
- ZOOSILUVXHVRJE-UHFFFAOYSA-N cyclopropanecarbonyl chloride Chemical compound ClC(=O)C1CC1 ZOOSILUVXHVRJE-UHFFFAOYSA-N 0.000 claims description 8
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 8
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 claims description 6
- YMGUBTXCNDTFJI-UHFFFAOYSA-N cyclopropanecarboxylic acid Chemical compound OC(=O)C1CC1 YMGUBTXCNDTFJI-UHFFFAOYSA-N 0.000 claims description 6
- 150000002170 ethers Chemical class 0.000 claims description 6
- 238000006386 neutralization reaction Methods 0.000 claims description 6
- 239000003208 petroleum Substances 0.000 claims description 6
- 229910052739 hydrogen Inorganic materials 0.000 claims description 5
- 239000001257 hydrogen Substances 0.000 claims description 5
- 229910052757 nitrogen Inorganic materials 0.000 claims description 5
- 235000011121 sodium hydroxide Nutrition 0.000 claims description 5
- 239000007787 solid Substances 0.000 claims description 5
- 239000002904 solvent Substances 0.000 claims description 5
- QAGHEHQMRFEQMB-UHFFFAOYSA-N 2-ethylidenepropanedioic acid Chemical class CC=C(C(O)=O)C(O)=O QAGHEHQMRFEQMB-UHFFFAOYSA-N 0.000 claims description 4
- KRZCOLNOCZKSDF-UHFFFAOYSA-N 4-fluoroaniline Chemical compound NC1=CC=C(F)C=C1 KRZCOLNOCZKSDF-UHFFFAOYSA-N 0.000 claims description 4
- BTJIUGUIPKRLHP-UHFFFAOYSA-N 4-nitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1 BTJIUGUIPKRLHP-UHFFFAOYSA-N 0.000 claims description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 4
- 238000010790 dilution Methods 0.000 claims description 4
- 239000012895 dilution Substances 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 4
- 238000004128 high performance liquid chromatography Methods 0.000 claims description 4
- 239000002245 particle Substances 0.000 claims description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 4
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 4
- 206010013786 Dry skin Diseases 0.000 claims description 3
- 150000001412 amines Chemical class 0.000 claims description 3
- 239000007864 aqueous solution Substances 0.000 claims description 3
- 150000001875 compounds Chemical class 0.000 claims description 3
- 238000000605 extraction Methods 0.000 claims description 3
- 239000012467 final product Substances 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 3
- 239000012044 organic layer Substances 0.000 claims description 3
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 claims description 3
- 238000005292 vacuum distillation Methods 0.000 claims description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 2
- 229910021529 ammonia Inorganic materials 0.000 claims description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 2
- 239000011734 sodium Substances 0.000 claims description 2
- 229910052708 sodium Inorganic materials 0.000 claims description 2
- 238000001291 vacuum drying Methods 0.000 claims description 2
- WRVHQEYBCDPZEU-UHFFFAOYSA-N 4-chloro-6,7-dimethoxyquinoline Chemical compound C1=CC(Cl)=C2C=C(OC)C(OC)=CC2=N1 WRVHQEYBCDPZEU-UHFFFAOYSA-N 0.000 claims 2
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 claims 2
- 238000004458 analytical method Methods 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 239000001301 oxygen Substances 0.000 claims 1
- 229920006395 saturated elastomer Polymers 0.000 claims 1
- 235000002639 sodium chloride Nutrition 0.000 claims 1
- 239000003960 organic solvent Substances 0.000 abstract description 16
- -1 (4 fluorophenyl) carbamoyl Chemical group 0.000 abstract description 9
- LVZWSLJZHVFIQJ-UHFFFAOYSA-N Cyclopropane Chemical compound C1CC1 LVZWSLJZHVFIQJ-UHFFFAOYSA-N 0.000 abstract description 4
- 239000002253 acid Substances 0.000 abstract description 4
- 239000011230 binding agent Substances 0.000 abstract description 4
- 238000000034 method Methods 0.000 abstract description 4
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 230000000087 stabilizing effect Effects 0.000 abstract description 2
- 150000001448 anilines Chemical class 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 description 10
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 7
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 6
- 239000003054 catalyst Substances 0.000 description 5
- 238000009833 condensation Methods 0.000 description 5
- 230000005494 condensation Effects 0.000 description 5
- 125000005843 halogen group Chemical group 0.000 description 5
- UJSZVZXINMWJKC-UHFFFAOYSA-N 2-chloro-6,7-dimethoxyquinoline Chemical class C1=C(Cl)N=C2C=C(OC)C(OC)=CC2=C1 UJSZVZXINMWJKC-UHFFFAOYSA-N 0.000 description 4
- QOGPNCUTXVZQSL-UHFFFAOYSA-N 6,7-dimethoxy-1h-quinolin-4-one Chemical compound C1=CC(O)=C2C=C(OC)C(OC)=CC2=N1 QOGPNCUTXVZQSL-UHFFFAOYSA-N 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 4
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 4
- 108091008605 VEGF receptors Proteins 0.000 description 4
- 102000009484 Vascular Endothelial Growth Factor Receptors Human genes 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- MFRIHAYPQRLWNB-UHFFFAOYSA-N sodium tert-butoxide Chemical compound [Na+].CC(C)(C)[O-] MFRIHAYPQRLWNB-UHFFFAOYSA-N 0.000 description 4
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 4
- 229940124676 vascular endothelial growth factor receptor Drugs 0.000 description 4
- 229910019213 POCl3 Inorganic materials 0.000 description 3
- 125000000217 alkyl group Chemical group 0.000 description 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 3
- PLIKAWJENQZMHA-UHFFFAOYSA-N 4-aminophenol Chemical compound NC1=CC=C(O)C=C1 PLIKAWJENQZMHA-UHFFFAOYSA-N 0.000 description 2
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 239000005695 Ammonium acetate Substances 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 206010060862 Prostate cancer Diseases 0.000 description 2
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 2
- 102000052575 Proto-Oncogene Human genes 0.000 description 2
- 108700020978 Proto-Oncogene Proteins 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical group [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- 229940043376 ammonium acetate Drugs 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000003638 chemical reducing agent Substances 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N dimethyl sulfoxide Natural products CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- PYLWMHQQBFSUBP-UHFFFAOYSA-N monofluorobenzene Chemical compound FC1=CC=CC=C1 PYLWMHQQBFSUBP-UHFFFAOYSA-N 0.000 description 2
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 2
- FAIAAWCVCHQXDN-UHFFFAOYSA-N phosphorus trichloride Chemical compound ClP(Cl)Cl FAIAAWCVCHQXDN-UHFFFAOYSA-N 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- XTHPWXDJESJLNJ-UHFFFAOYSA-N sulfurochloridic acid Chemical compound OS(Cl)(=O)=O XTHPWXDJESJLNJ-UHFFFAOYSA-N 0.000 description 2
- QJNRQJGEIYYPRW-UHFFFAOYSA-N 2,3-dimethoxyquinoline Chemical class C1=CC=C2N=C(OC)C(OC)=CC2=C1 QJNRQJGEIYYPRW-UHFFFAOYSA-N 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 208000037196 Medullary thyroid carcinoma Diseases 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- JOOMLFKONHCLCJ-UHFFFAOYSA-N N-(trimethylsilyl)diethylamine Chemical compound CCN(CC)[Si](C)(C)C JOOMLFKONHCLCJ-UHFFFAOYSA-N 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 1
- 102000004022 Protein-Tyrosine Kinases Human genes 0.000 description 1
- 108090000412 Protein-Tyrosine Kinases Proteins 0.000 description 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 230000033115 angiogenesis Effects 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- AQEFLFZSWDEAIP-UHFFFAOYSA-N di-tert-butyl ether Chemical compound CC(C)(C)OC(C)(C)C AQEFLFZSWDEAIP-UHFFFAOYSA-N 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 150000002240 furans Chemical class 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 208000023356 medullary thyroid gland carcinoma Diseases 0.000 description 1
- 230000001394 metastastic effect Effects 0.000 description 1
- 206010061289 metastatic neoplasm Diseases 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- XONPDZSGENTBNJ-UHFFFAOYSA-N molecular hydrogen;sodium Chemical compound [Na].[H][H] XONPDZSGENTBNJ-UHFFFAOYSA-N 0.000 description 1
- FMJFXAHUDOUFGK-UHFFFAOYSA-N n,n-dimethoxyformamide Chemical class CON(OC)C=O FMJFXAHUDOUFGK-UHFFFAOYSA-N 0.000 description 1
- 230000000505 pernicious effect Effects 0.000 description 1
- RPDAUEIUDPHABB-UHFFFAOYSA-N potassium ethoxide Chemical compound [K+].CC[O-] RPDAUEIUDPHABB-UHFFFAOYSA-N 0.000 description 1
- BDAWXSQJJCIFIK-UHFFFAOYSA-N potassium methoxide Chemical compound [K+].[O-]C BDAWXSQJJCIFIK-UHFFFAOYSA-N 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 208000013818 thyroid gland medullary carcinoma Diseases 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
The invention discloses a kind of synthetic method of antineoplastic drug cabozant inib; card is obtained in 5～20 DEG C of 0.5～2h of reaction in organic solvent with 1 ((4 fluorophenyl) carbamoyl) cyclopropane base carboxylic acid halides, acid binding agent using 4 (6,7 dimethoxy-quinoline, 4 epoxide) phenyl amines to win for Buddhist nun；Using technical scheme, its raw material is cheap, and mild condition is easy to operate, and process stabilizing is reproducible, and molar yield is high, low cost, therefore the present invention is that a kind of suitable industrialized production card wins the method for Buddhist nun.
Description
Technical field
The present invention relates to a kind of medical synthesis field, more particularly to increasing and expansion with medullary thyroid carcinoma, prostate cancer
It is target to dissipate relevant proto-oncogene encoded protein products (MET) and vascular endothelial growth factor receptor (VEGFR) EGFR-TK
Point, suppresses the transfer of tumour and the synthetic method of Angiogenesiss antineoplastic drug cabozant inib (Cabozant inib).
Background technology
Card is rich for Buddhist nun, English entitled (Cabozant inib), also known as XL184；Chemical name：N- [4- [(6,7- dimethoxies
Base -4- quinolyls) epoxide] phenyl]-N- (4- fluorophenyls) -1,1- cyclopropane diformamide structural formulas：
Molecular formula：C28H24FN3O5
CAS NO.：849217-68-1
Molecular weight：501.5
By targeted inhibition proto-oncogene encoded protein products (MET), vascular endothelial growth factor receptor (VEGFR) and
Tyrosine-kinase enzyme is received (RET) signal path and plays antitumor action, kills tumour cell, reduces metastases and suppress blood
Pipe is generated.Effectively treatment prostate cancer, malignant tumour and can not surgery excision pernicious Locally Advanced or metastatic thyroid gland
Cephaloma (MTC).76% patient after the rich treatment for Buddhist nun (Cabozant inib) of card is received, tumor section or whole atrophys.
The content of the invention
For the deficiencies in the prior art, present invention offer is a kind of simply efficiently, be suitable to the antitumor of industrialized production application
The rich synthesis path for Buddhist nun (Cabozantinib) of medicine card.
For achieving the above object, the technical solution used in the present invention is as follows：
A kind of synthetic method of antineoplastic drug cabozant inib, using 4- (6,7- dimethoxy-quinoline -4- epoxides) -
Phenyl amine is reacted in -5～20 DEG C in organic solvent with 1- ((4- fluorophenyls) carbamoyl) cyclopropane base carboxylic acid halides, acid binding agent
0.5～2h obtains card and wins for Buddhist nun, and its reaction equation is：
In formula, R is any one in halogen atom；
Wherein, according to molar ratio computing, 4- (6,7- dimethoxy-quinoline -4- epoxides)-phenyl amines and 1- ((4- fluorophenyls) ammonia
Base formoxyl) cyclopropane base carboxylic acid halides, acid binding agent, the ratio of organic solvent be：1: 1: 1: 1: 4.5～1: 1.5: 1.3: 1.5: 8.
Any one in described acid binding agent sodium carbonate, sodium acid carbonate, potassium carbonate, calcium carbonate or ammoniacal liquor.
Described organic solvent be acetonitrile, pyridine, N, N- dimethoxy formamides, N, TMSDEA N diethylamine base formamide, methyl
Any one in tertbutyl ether or tetrahydrofuran.
Described 4- (6,7- dimethoxy-quinoline -4- epoxides)-phenyl amine, its synthetic method is：With 4- hydroxyl -6,7- bis-
Methoxy quinoline is raw material, in organic solvent, with acylating agent in 100～120 DEG C of reaction responses 4～7 hours, generate 4- halogen-
6,7- dimethoxy-quinolines；Again 20～25 DEG C in organic solvent with condensation catalyst and para-aminophenol, 100～120 DEG C
Reaction obtains 6,7- dimethoxy-4 's-(4-nitrophenoxy) quinoline in 2～6 hours；Its reaction equation is：
Wherein, R is any one in halogen atom
Wherein, according to the molar ratio：Described 4- hydroxyl -6,7- dimethoxy-quinolines and acylating agent, organic solvent are：1∶
1: 3～1: 3: 7；
Wherein, according to the molar ratio, described 4- halogen -6,7- dimethoxy-quinolines with to amine phenol, condensation catalyst, have
The mol ratio of machine solvent is：1: 1: 1: 4.5～1: 1.5: 1.3: 8.
Described 4- (6,7- dimethoxy-quinoline -4- epoxides)-phenyl amine, its synthetic method is：With 4- hydroxyl -6,7- bis-
Methoxy quinoline is raw material, in organic solvent, with acylating agent in 100～120 DEG C of reaction responses 4～7 hours, generate 4- halogen-
6,7- dimethoxy-quinolines；Add organic solvent, condensation catalyst and p-nitrophenols again at 20～25 DEG C, and in 100～
120 DEG C of reactions obtain 6,7- dimethoxy-4 's-(4-nitrophenoxy) quinoline in 2～6 hours；4- is obtained then at 30～40 DEG C of reduction nitros
(6,7- dimethoxy-quinoline -4- epoxides)-phenyl amine.Its reaction equation is：
Wherein, R is any one in halogen atom
Wherein, according to the molar ratio：Described 4- hydroxyl -6,7- dimethoxy-quinolines and acylating agent, organic solvent are：1∶
1: 3～1: 3: 7；
Wherein, according to the molar ratio, described 4- halogen -6,7 dimethoxy-quinolines and p-nitrophenol, condensation catalyst,
The mol ratio of organic solvent is：1: 1: 1: 4.5～1: 1.5: 1.3: 8；
Wherein reducing agent used by nitro reduction is iron powder-ammonium acetate or Pd/C, in an amount of from 6,7- dimethoxy-4 's-(4- nitre
Phenoxyl) quinoline weight 1%～25%；Organic solvent amount is 2～8 times of its weight.
Described organic solvent be acetonitrile, DMF, N, N- DEFs, N, N- dimethylacetamides
Amine, methyl tertiary butyl ether(MTBE), toluene, benzene or tetrahydrofuran etc.；
Described acylating agent is thionyl chloride, oxalyl chloride, POCl3, phosphorus trichloride, phosphorus pentachloride, chlorosulfuric acid, phosphinylidyne
Any one in chlorine, dihalo triphenylphosphine.
Described condensation catalyst is sodium methoxide, caustic alcohol, sodium tert-butoxide, potassium methoxide, potassium ethoxide, potassium tert-butoxide, amino
Any one in sodium, sodium hydrogen.
Reducing agent used by described nitro reduction is any one in iron powder-ammonium acetate or Pd/C.
Described 1- ((4- fluorophenyls) carbamoyl) cyclopropane base carboxylic acid halides, its synthetic method is：With 1,1- cyclopropane
Dioctyl phthalate or derivatives thereof be raw material, in organic solvent with acylating agent in 0～10 DEG C react 0.5h, then with to fluorobenzene
Amine reacts 2～3h in 0～10 DEG C and obtains 1- ((4- fluorophenyls) carbamoyl) cyclopropane-carboxylic acid or derivatives thereof；Again organic
Solvent adds acylating agent in 15～30 DEG C, and obtains in 15～35 DEG C of 0.5～2h of reaction.Its reaction equation is：
Wherein, R is any one in halogen atom；R1、R2For at least in alkyl, halogenated alkyl thing, halogen atom, hydrogen atom
Kind；Described alkyl is methyl, ethyl, propyl group, isopropyl, butyl, any one in the tert-butyl group；
Wherein, 1,1- ethylene-malonic acids or derivatives thereof and the mol ratio of para-fluoroaniline, acylating agent and solvent are 1:
0.8: 1: 2～1: 1.2: 1.5: 10；
1- ((4- fluorophenyls) carbamoyl) cyclopropane-carboxylic acid or derivatives thereof is 1 with the mol ratio of acylating agent, solvent:
0.8: 1～1: 1.5: 2；
The acylating agent of the reaction is thionyl chloride, oxalyl chloride, POCl3, phosphorus trichloride, phosphorus pentachloride, sulfonyl
Any one in chlorine, phosgene, dihalo triphenylphosphine；
The organic solvent of the reaction is acetonitrile, DMF, N, N- DEFs, N, N- diformazans
Yl acetamide, methyl tertiary butyl ether(MTBE), toluene, benzene or tetrahydrofuran etc..
Using the beneficial effect of technical scheme it is：Raw material is cheap, mild condition, easy to operate, process stabilizing
Reproducible, molar yield is high, low cost, therefore the present invention is that a kind of suitable industrialized production card wins the method for Buddhist nun.
Specific embodiment
Below according to specific embodiment, the invention will be further described.
Embodiment 1
(1) synthesis of 4- (- 6,7 dimethoxy-quinoline -4- epoxides)-phenyl amine
1. chloro- 6,7 dimethoxy-quinolines of 4- are synthesized
By POCl3 161g (1.05mol) with adding to containing after DMA 200ml (2.15mol) dilutions
4- hydroxyl -6, in 7- dimethoxy-quinoline 205.2g (1.0mol) and 300ml (3.22mol) DMA solution,
It is heated to 100～120 DEG C, reaction 4～7 hours (when HPLC shows that raw material is considered as reaction completely when being less than 3% unreacted).Reaction
After room temperature is down to after complete, 200ml frozen water is added, PH=7～8 is neutralized to 30% sodium hydroxide solution, temperature control during neutralization
Below 25 DEG C.After neutralization is finished, continue stirring 1 hour, fully separate out solid particle, then filter；Filter cake is washed with 200ml
Wash 2 times, with 60～70 DEG C of dryings after filtration, obtain the chloro- 6.7- dimethoxy-quinolines 164.1g of yellow-white powder 4-, molar yield
73.5%, 131.2～132.6 DEG C of fusing point.1H-NMR (400MHz, DMSO-d6/ppm)；δ 3.95 (s, 3H), 3.96 (s, 3H),
7.35 (s, 1H), 7.43 (s, 1H), 7.54 (d, 1H), 8.59 (d, 1H).
2. synthesize 4- (- 6,7 dimethoxy-quinoline -4- epoxides)-phenyl amine
PAP 120g (1.1mol) is dissolved in 150ml (1.61mol) DMA, in 20～
25 DEG C, it is added slowly to the 400ml of chloro- 6, the 7- dimethoxy-quinolines 200g (0.9mol) of 171g containing sodium tert-butoxide (0.9mol) and 4-
(4.30mol) in DMA solution, reactant liquor is heated to into 100 DEG C～120 DEG C after dripping, is reacted 2 hours
Starting material left amount is detected with HPLC afterwards, stopped reaction when 2% unreacteds of ＜, be cooled to room temperature, stir in being poured into 1L frozen water
Filter after mixing 1～2 hour, filter cake 200ml water washings 2 times, and be vacuum dried in 35 DEG C, obtain ivory buff powder 4- (- 6,
7 dimethoxy-quinoline -4- epoxides)-phenyl amine 208.3g, molar yield 78.1%, 214.3～215.0 DEG C of fusing point,1H-NMR
(DMSO-d6,300MHz) δ 3.93 (6H, s), 5.16 (2H, s), 6.37 (1H, d=5.4Hz), 6.67 (2H, d, J=8.7Hz),
6.93 (2H, d, J=8.7Hz), 7.36 (1H, s), 7.50 (1H, s), 8.43 (1H, d, J=5.4Hz).
(2) synthesis of 1- ((4- fluorophenyls) carbamoyl) cyclopropanecarbonyl chloride
500g (6.93mol) tetrahydrofuran is added to 320g (2.46mol) 1,1- ethylene-malonic acids, after 0.5 hour, in
0～10 DEG C of dropwise addition 300g (2.52mol) thionyl chloride, reacts 0.5h at this temperature after completion of dropping.It is subsequently adding Jing 200g
(2.77mol) 240g (2.16mol) para-fluoroaniline after tetrahydrofuran dilution, does 0～10 DEG C of 2～3h of reaction.After completion of the reaction
The extraction of 500g ethyl acetate is added, after point liquid, successively with 400ml30% sodium hydrate aqueous solutions, 500ml water, 500ml saturations food
Salt water washing, then to upper organic layer vacuum distillation, obtains buff powder.
500ml petroleum ethers are added, agitator treating was filtered after 1 hour, filter cake 1kg methyl alcohol dissolves, after 30 minutes, slowly
Add 1L water, material slowly to separate out, add stirring and filter for 1～2 hour, then Jing after 500ml water, 500ml petroleum ethers, in 55
DEG C drying, obtain off-white powder 1- ((4- fluorophenyls) carbamoyl) cyclopropane-carboxylic acid 391.2g, molar yield 81.1%.1H
NMR (400MHz, DMSO-d6)：δ 13.06 (s, 1H), 10.55 (s, 1H), 7.60 (m, 2H), 7.12 (m, 2H), 1.39 (s,
4H)。
To add in 179.1g (1.41mol) oxalyl chloride in 15～30 DEG C to ((the 4- fluorobenzene containing 300g (1.34mol) 1-
Base)-carbamyl) cyclopropyl carboxylic acid and 100g (1.39mol) tetrahydrofuran solution in, add and react 0.5 after 15～35 DEG C
～2h, obtains final product 1- ((4- fluorophenyls) carbamoyl) cyclopropanecarbonyl chloride, without the need for separating from reactant liquor, directly uses.
(3) N- [4- [(6,7- dimethoxy-4 's-quinolyl) epoxide] phenyl]-N- (4- fluorophenyls) -1,1- cyclopropane two
The synthesis of formamide
By 4- (6,7- dimethoxy-quinoline -4- base epoxides) aniline 417g (1.41mol) 1.5L (18.5mol) tetrahydrochysene furans
Mutter and 500g (1.66mol) potassium carbonate is added after dissolving, then drop to step 1- ((4- fluorophenyls) carbamoyl) ring third
Alkane formyl chloride reactant liquor, reacts in 20 DEG C, reacts 0.5～2h hours.After reaction terminates, 500ml water is added, at 40～45 DEG C
Stir the solution about 2 hours, crystallization, filtration, with 500ml water washings 3 times, then filter cake is vacuum dried at 45 DEG C, obtains titled
Compound 682.4g (1.36mol), 186.6～187.3 DEG C of fusing point, molar yield 96.5%.H NMR (400MHz, d6-DMSO)：δ
10.2 (s, 1H), 10.05 (s, 1H), 8.4 (s, 1H), 7.8 (m, 2H), 7.65 (m, 2H), 7.5 (s, 1H), 7.35 (s, 1H),
7.25 (m, 2H), 7.15 (m, 2H), 6.4 (s, 1H), 4.0 (d, 6H), 1.5 (s, 4H)
Embodiment 2
(1) synthesis of 4- (- 6,7 dimethoxy-quinoline -4- epoxides)-phenyl amine
Chloro- 6,7 dimethoxy-quinolines of 1 synthesis 4-
Thionyl chloride 1.65kg (13.9mol) is added dropwise to hydroxyl -6 containing 2.2Kg (10.72mol) 4-, 7- dimethoxys
In 5.3L (57mol) the DMA solution of quinoline, 100～120 DEG C after adding, are heated to, are reacted 4～7 hours
(when HPLC shows that raw material is considered as reaction completely when being less than 3% unreacted).Room temperature is down to after having reacted, 2.2L frozen water is added, is used
30% sodium hydroxide solution is neutralized to PH=7～8, and during neutralization, temperature control is below 25 DEG C.After neutralization is finished, continue stirring 1
Hour, solid particle is fully separated out, is filtered；Filter cake 1L water washings 2 times, and in 60～70 DEG C of dryings, obtain yellow-white powder
The chloro- 6.7- dimethoxy-quinolines 1775.9g of 4-, molar yield 74.2%, 131.4～132.7 DEG C of fusing point.1H-NMR (400MHz,
DMSO-d6/ppm)；δ 3.95 (s, 3H), 3.96 (s, 3H), 7.35 (s, 1H), 7.43 (s, 1H), 7.54 (d, 1H), 8.59 (d,
1H)。
2 synthesis 6,7- dimethoxy-4 's-(4-nitrophenoxy) quinoline
P-nitrophenol 523g (3.76mol) is dissolved in 600ml (6.45mol) DMA, in 20～
25 DEG C, be added slowly to chloro- 6, the 7- dimethoxy-quinolines 800g (3.58mol) of 482g containing potassium tert-butoxide (4.3mol) and 4- and
In 1.5L (16.1mol) DMA solution, reactant liquor is heated to into 100 DEG C～120 DEG C after dripping, reaction 2
Hour.Reactant liquor is cooled to after room temperature, is poured into, filter cake 2L water washings 2 times, so
It is vacuum dried after 35 DEG C, obtains ivory buff powder 6,7- dimethoxy-4 's-(4-nitrophenoxy) quinoline 918.2g, mole
Yield 78.6%.1H NMR (400MHz, DMSO-d6) δ (ppm)：8.61 (d, J=5.1Hz, 1H), 8.36-8.32 (m, 2H),
7.46-7.42 (m, 3H), 7.37 (s, 1H), 6.87 (d, J=5.1Hz, 1H), 3.96 (s, 3H), 3.88 (s, 3H)
3 synthesis 4- (- 6,7 dimethoxy-quinoline -4- epoxides)-phenyl amines
By 100g (0.306mol) 6,7- dimethoxy-4 's-(4-nitrophenoxy) quinoline 300g N, N- diethyl first
During autoclave is added after acid amides dissolving, 10%Pd/C15g is added, reacted under the conditions of 30～40 DEG C, Hydrogen Vapor Pressure 2.8MPa, when
As do not react during re-absorption hydrogen complete.After removing most of solvent, pour in 150ml water and stir 1 hour, separate out solid
Grain after filtering, with 100ml water washings 2 times, dry in 60 DEG C, obtain 4- (- 6,7 dimethoxy-quinoline -4- epoxides)-benzene again by filter cake
Base amine 86.3g, 213.2～213.7 DEG C of fusing point, molar yield 95.2%.1H-NMR (DMSO-d6,300MHz) δ 3.93 (6H,
S), 5.16 (2H, s), 6.37 (1H, d=5.4Hz), 6.67 (2H, d, J=8.7Hz), 6.93 (2H, d, J=8.7Hz), 7.36
(1H, s), 7.50 (1H, s), 8.43 (1H, d, J=5.4Hz).
(2) synthesis of 1- ((4- fluorophenyls) carbamoyl) cyclopropanecarbonyl chloride
1100g (15.25mol) tetrahydrofuran is added to 700g (5.38mol) 1,1- ethylene-malonic acids, after 0.5 hour,
704.4g (5.92mol) thionyl chloride is added dropwise in 0～10 DEG C, 0.5h after completion of dropping, is reacted at this temperature.It is subsequently adding Jing
537.8g (4.84mol) para-fluoroaniline after the dilution of 200g (2.77mol) tetrahydrofuran, reacts 2～3h in 0～10 DEG C.Reaction
The extraction of 1100g ethyl acetate is added after finishing, after point liquid, is satisfied with 880ml30% sodium hydrate aqueous solutions, 1L water, 800ml successively
And brine It, then to upper organic layer vacuum distillation, obtain buff powder.
1L petroleum ethers are added, agitator treating was filtered after 1 hour, filter cake 2kg methyl alcohol dissolves, it is after 30 minutes, slow to add
Enter 2.3L water, material is slowly separated out, add stirring and filter for 1～2 hour, then Jing after 1L water, 1L petroleum ethers, in 55 DEG C of vacuum
Drying, obtains off-white powder 892.3g, molar yield 82.6%.1H NMR (400MHz, DMSO-d6)：δ 13.06 (s, 1H),
10.55 (s, 1H), 7.60 (m, 2H), 7.12 (m, 2H), 1.39 (s, 4H).
To add in 488.6g (3.85mol) oxalyl chloride in 15～30 DEG C to ((the 4- fluorobenzene containing 727.6g (3.26mol) 1-
Base)-carbamyl) cyclopropyl carboxylic acid and 245g (3.4mol) tetrahydrofuran solution in.Completion of dropwise addition is reacted after 15～35 DEG C
0.5～2h, obtains final product 1- ((4- fluorophenyls) carbamoyl) cyclopropanecarbonyl chloride, without the need for separating from reactant liquor, directly uses.
(3) N- [4- [(6,7- dimethoxy-4 's-quinolyl) epoxide] phenyl]-N- (4- fluorophenyls) -1,1- cyclopropane two
The synthesis of formamide
By 4- (6,7- dimethoxy-quinoline -4- base epoxides) aniline 995.6g (3.36mol) 3.6L (44.39mol) four
1210g (4.03mol) potassium carbonate is added after the dissolving of hydrogen furans, step 1- ((4- fluorophenyls) carbamyl after dissolving, is dropped to
Base) cyclopropanecarbonyl chloride reactant liquor, reacts 0.5～2h in -5～20 DEG C.After reaction terminates, 1L water is added, at 40～45 DEG C
Stir the solution about 2 hours, crystallization, filtration, with 700ml water washings 3 times, then filter cake is vacuum dried at 45 DEG C, obtains titled
Compound 1589.8g (3.17mol), 186.3～187.1 DEG C of fusing point, molar yield 97.2%.1H NMR (400MHz, d6-
DMSO)：δ 10.2 (s, 1H), 10.05 (s, 1H), 8.4 (s, 1H), 7.8 (m, 2H), 7.65 (m, 2H), 7.5 (s, 1H), 7.35
(s, 1H), 7.25 (m, 2H), 7.15 (m, 2H), 6.4 (s, 1H), 4.0 (d6H), 1.5 (s, 4H).
Claims (1)
1. a kind of synthetic method of antineoplastic drug cabozant inib, it is characterised in that：
(1) synthesis of 4- (6,7- dimethoxy-quinoline -4- epoxides)-phenyl amine
Chloro- 6, the 7- dimethoxy-quinolines of 1 synthesis 4-
Thionyl chloride 1.65kg, 13.9mol are added dropwise to hydroxyl -6 containing 2.2Kg, 10.72mol4-, 7- dimethoxy-quinolines
In 5.3L, 57mol DMA solution, 100～120 DEG C after adding, are heated to, are reacted 4～7 hours；Work as HPLC
Show that raw material is considered as reaction when being less than 3% unreacted complete；Room temperature is down to after having reacted, 2.2L frozen water is added, is used 30% hydrogen-oxygen
Change sodium solution and be neutralized to pH=7～8, temperature control is below 25 DEG C during neutralization；After neutralization is finished, continue stirring 1 hour, fully
Solid particle is separated out, is filtered；Filter cake 1L water washings 2 times, and in 60～70 DEG C of dryings, obtain yellow-white powder 4- chloro- 6,7-
Dimethoxy-quinoline 1775.9g, molar yield 74.2%, 131.4～132.7 DEG C of fusing point；1H-NMR (400MHz, DMSO-d6/
ppm)；δ 3.95 (s, 3H), 3.96 (s, 3H), 7.35 (s, 1H), 7.43 (s, 1H), 7.54 (d, 1H), 8.59 (d, 1H)；
It is 2-in-1 into 6,7- dimethoxy-4 's-(4-nitrophenoxy) quinoline
P-nitrophenol 523g, 3.76mol are dissolved in 600ml, 6.45mol DMA, in 20～25 DEG C,
Be added slowly to 482g containing potassium tert-butoxide, 4.3mol and 4- chloro- 6,7- dimethoxy-quinolines 800g, 3.58mol and 1.5L,
In 16.1molN, N- dimethylacetamide solution, reactant liquor is heated to into 100 DEG C～120 DEG C after dripping, is reacted 2 hours；Will
After reactant liquor is cooled to room temperature, pours into, filter cake 2L water washings 2 times, then in 35
DEG C vacuum drying, obtain ivory buff powder 6,7- dimethoxy-4 's-(4-nitrophenoxy) quinoline 918.2g, molar yield
78.6%；1H NMR (400MHz, DMSO-d6) δ (ppm)：8.61 (d, J=5.1Hz, 1H), 8.36-8.32 (m, 2H), 7.46-
7.42 (m, 3H), 7.37 (s, 1H), 6.87 (d, J=5.1Hz, 1H), 3.96 (s, 3H), 3.88 (s, 3H)；
3 synthesis 4- (6,7- dimethoxy-quinoline -4- epoxides)-phenyl amines
By 100g, 0.306mol6,7- dimethoxy-4 's-(4-nitrophenoxy) quinoline 300g N, N- DEFs are molten
During autoclave is added after solution, 10%Pd/C15g is added, reacted under the conditions of 30～40 DEG C, Hydrogen Vapor Pressure 2.8MPa, when no longer inhaling
As react when receiving hydrogen complete；After removing most of solvent, pour in 150ml water and stir 1 hour, separate out solid particle and pass through
After filter, filter cake with 100ml water washings 2 times, is dried in 60 DEG C, obtains 4- (6,7- dimethoxy-quinoline -4- epoxides)-phenyl amine again
86.3g, 213.2～213.7 DEG C of fusing point, molar yield 95.2%；1H-NMR (DMSO-d6,300MHz) δ 3.93 (6H, s),
5.16 (2H, s), 6.37 (1H, d=5.4Hz), 6.67 (2H, d, J=8.7Hz), 6.93 (2H, d, J=8.7Hz), 7.36 (1H,
S), 7.50 (1H, s), 8.43 (1H, d, J=5.4Hz)；
(2) synthesis of 1- ((4- fluorophenyls) carbamoyl) cyclopropanecarbonyl chloride
To 700g, 5.38mol 1,1- ethylene-malonic acids add 1100g, 15.25mol tetrahydrofuran, after 0.5 hour, in 0～
10 DEG C of dropwise addition 704.4g, 5.92mol thionyl chlorides, react 0.5h at this temperature after completion of dropping；Be subsequently adding Jing 200g,
537.8g, 4.84mol para-fluoroaniline after the dilution of 2.77mol tetrahydrofurans, reacts 2～3h in 0～10 DEG C；After completion of the reaction plus
Enter the extraction of 1100g ethyl acetate, after point liquid, successively with 30% sodium hydrate aqueous solutions of 880ml, 1L water, 800ml saturated common salts
Water washing, then to upper organic layer vacuum distillation, obtains buff powder；
1L petroleum ethers are added, agitator treating was filtered after 1 hour, filter cake 2kg methyl alcohol dissolves, and after 30 minutes, is slowly added to
2.3L water, material are slowly separated out, and are added stirring and are filtered for 1～2 hour, then Jing after 1L water, 1L petroleum ethers, dry in 55 DEG C of vacuum
It is dry, obtain off-white powder 892.3g, molar yield 82.6%；1H NMR (400MHz, DMSO-d6)：δ 13.06 (s, 1H),
10.55 (s, 1H), 7.60 (m, 2H), 7.12 (m, 2H), 1.39 (s, 4H)；
To add in 488.6g, 3.85mol oxalyl chloride in 15～30 DEG C to ((4- fluorophenyls)-ammonia containing 727.6g, 3.26mol1-
Base formyl) cyclopropyl carboxylic acid and 245g, 3.4mol tetrahydrofuran solution in, completion of dropwise addition reacts 0.5～2h after 15～35 DEG C,
1- ((4- fluorophenyls) carbamoyl) cyclopropanecarbonyl chloride is obtained final product, without the need for separating from reactant liquor, is directly used；
(3) N- [4- [(6,7- dimethoxy-4 's-quinolyl) epoxide] phenyl]-N- (4- fluorophenyls) -1,1- cyclopropane, two formyl
The synthesis of amine
By 4- (6,7- dimethoxy-quinoline -4- base epoxides) aniline 995.6g, 3.36mol 3.6L, 44.39mol tetrahydrofuran
1210g potassium carbonate is added after dissolving, step 1- ((4- fluorophenyls) carbamoyl) cyclopropanecarbonyl chloride after dissolving, is dropped to
Reactant liquor, reacts 0.5～2h in -5 DEG C, after reaction terminates, adds 1L water, stirs the solution about 2 hours at 40～45 DEG C, analyses
It is brilliant, filter, with 700ml water washings 3 times, then filter cake is vacuum dried at 45 DEG C, obtains title compound 1589.8g, 3.17mol,
186.3～187.1 DEG C of fusing point, molar yield 97.2%；1H NMR (400MHz, d6-DMSO)：δ 10.2 (s, 1H), 10.05 (s,
1H), 8.4 (s, 1H), 7.8 (m, 2H), 7.65 (m, 2H), 7.5 (s, 1H), 7.35 (s, 1H), 7.25 (m, 2H), 7.15 (m,
2H), 6.4 (s, 1H), 4.0 (d6H), 1.5 (s, 4H).
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310631287.3A CN103664778B (en) | 2013-11-27 | 2013-11-27 | A kind of synthetic method of antineoplastic drug cabozant inib |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310631287.3A CN103664778B (en) | 2013-11-27 | 2013-11-27 | A kind of synthetic method of antineoplastic drug cabozant inib |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103664778A CN103664778A (en) | 2014-03-26 |
| CN103664778B true CN103664778B (en) | 2017-04-05 |
Family
ID=50303658
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310631287.3A Expired - Fee Related CN103664778B (en) | 2013-11-27 | 2013-11-27 | A kind of synthetic method of antineoplastic drug cabozant inib |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103664778B (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2983639A1 (en) * | 2013-04-04 | 2016-02-17 | Exelixis, Inc. | Drug combinations to treat cancer |
| IL247035B2 (en) * | 2014-02-14 | 2023-03-01 | Exelixis Inc | Crystalline solid forms of n-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-n'-(4-fluorophenyl) cyclopropane-1, 1-dicarboxamide, processes for making, and methods of use |
| CN104788372B (en) * | 2014-07-25 | 2018-01-30 | 上海圣考医药科技有限公司 | A kind of deuterated card is rich to replace Buddhist nun's derivative, its preparation method, application and its intermediate |
| CN107353246A (en) * | 2016-12-27 | 2017-11-17 | 辅仁药业集团熙德隆肿瘤药品有限公司 | It is a kind of to prepare the rich method for Buddhist nun of antineoplastic card |
| CN109836381A (en) * | 2017-11-29 | 2019-06-04 | 连云港恒运药业有限公司 | The preparation method of polyceptor tyrosine kinase inhibitor and its intermediate |
| CN108872446B (en) * | 2018-08-31 | 2021-02-05 | 张云 | Quantitative detection method for cabozantinib drug residue in meat product |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA108618C2 (en) * | 2009-08-07 | 2015-05-25 | APPLICATION OF C-MET-MODULATORS IN COMBINATION WITH THEMOSOLOMID AND / OR RADIATION THERAPY FOR CANCER TREATMENT | |
| CN103304552B (en) * | 2012-03-09 | 2016-12-28 | 广东东阳光药业有限公司 | Substituted pyridine compounds and using method thereof and purposes |
-
2013
- 2013-11-27 CN CN201310631287.3A patent/CN103664778B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN103664778A (en) | 2014-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103664778B (en) | A kind of synthetic method of antineoplastic drug cabozant inib | |
| CN105820126B (en) | A kind of preparation method of olaparib | |
| CN102532116B (en) | Synthesis method of anti-tumor targeted therapeutic drug tivozanib | |
| CN104151152B (en) | A kind of three-cycle method for preparing phenoxyacetic acid without waste water | |
| CN103910672A (en) | Preparation method for vismodegib | |
| CN105566215B (en) | A kind of Rui Gefeini preparation method | |
| CN103483324B (en) | The new preparation process of lapatinibditosylate | |
| CN104072492A (en) | Synthetic method of anti-tumor targeting therapy drug Tivozanib | |
| CN104945383B (en) | Hold in the palm his preparation method of pyrrole department | |
| CN106146518A (en) | A kind of bruton's tyrosine kinase inhibitor intermediate and preparation method thereof | |
| CN104003934B (en) | The synthesis of the fluoro-2-pyridine carboxylic acid of the chloro-3-of 6- | |
| CN104910135A (en) | Preparation method of new crystal form of dexrabeprazole sodium | |
| CN106946880B (en) | A method of preparing Rui Boxini intermediate | |
| CN109988108A (en) | A kind of rich preparation method for Buddhist nun of card | |
| CN108892659A (en) | A kind of canagliflozin impurity and preparation method thereof | |
| CN101967120A (en) | Preparation method of 2-p-chlorobenzyl pyridine | |
| CN105367497B (en) | A kind of slimming drugs hydrochloric acid green card color woods and its preparation method of intermediate | |
| CN101891693A (en) | New method for preparing fluconazole | |
| CN103351333B (en) | A kind of Aryl pyridine derivative compound and preparation method thereof | |
| CN106008364A (en) | Preparation method of selexipag | |
| CN103739417A (en) | Method for synthesizing aromatic primary amine in circulating water phase system | |
| CN106117154B (en) | A kind of neighbour's aryloxy group -1,4- diaryl -1,2,3- triazole derivatives and its preparation method and application | |
| CN104496995A (en) | Method for preparing 3-ethynyl imidazo[1,2-b]pyridazine | |
| CN104672180B (en) | Chiral preparation method of [(1S)-3-methyl-1-[[(2R)-2-methylepoxyethyl]carbonyl]butyl]tert-butyl carbamate | |
| CN112390749B (en) | A method for synthesizing cabozantinib and its intermediates |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20170405 Termination date: 20171127 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |